Which of the following is a long acting M3 – antagonist used for bronchial asthma
**Core Concept**
In bronchial asthma, muscarinic receptors play a significant role in airway constriction. M3 muscarinic receptors are involved in smooth muscle contraction, leading to bronchoconstriction. Long-acting M3 antagonists can help in managing asthma by inhibiting this receptor, thereby reducing bronchoconstriction.
**Why the Correct Answer is Right**
Ipratropium bromide is a long-acting M3 muscarinic receptor antagonist that is used in the management of bronchial asthma. It works by competitively blocking the action of acetylcholine at M3 receptors, which leads to relaxation of smooth muscle in the airway walls, thereby reducing bronchoconstriction. This results in improved lung function and reduced symptoms in patients with asthma.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify a long-acting M3 antagonist.
**Option B:** This option is incorrect as it is not a well-known long-acting M3 antagonist used in bronchial asthma.
**Option C:** This option is incorrect as it is not a specific drug and does not match the description of a long-acting M3 antagonist.
**Clinical Pearl / High-Yield Fact**
It is essential to note that ipratropium bromide is often used in combination with other medications, such as beta-2 agonists, to provide better control of asthma symptoms.
**Correct Answer:** C. Ipratropium bromide.